ClinicalTrials.gov
ClinicalTrials.gov Menu

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03291444
Recruitment Status : Recruiting
First Posted : September 25, 2017
Last Update Posted : May 15, 2018
Sponsor:
Collaborators:
Shenzhen Geno-Immune Medical Institute
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Information provided by (Responsible Party):
Zhujiang Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 1, 2021
  Estimated Study Completion Date : March 1, 2022